Enzyme characteristics include the ability to increase the rate of reaction without changing the nature or being synthesized in laboratories, examples include metals and enzymes.
Enzymes are large molecules and can be denatured or degraded, accelerate chemical reactions, and are required for normal activity of cells in the body.
Pancreatic proteases are not synthesised in their final active form, they are synthesised in catalytically inactive molecules known as zymogens, which include trypsinogen, chymotrypsinogen, and procarboxypeptidase.
Certain cellular processes are contained in separate organelles, for example, enzymes involved in the later stages of cellular respiration carry out reactions exclusively in the mitochondria.
Enzymes are proteins except ribozymes, are large molecules and can be denatured or degraded, accelerate chemical reactions, and are required for normal activity of cells in the body.
The Michaelis - Menten equation is a model of enzyme kinetics which explains how the rate of an enzyme-catalysed reaction depends on the concentration of the enzyme and its substrate.
Enzymes provide a transition state with a lower activation energy, allowing more substrate to reach the transition state (ES) and increase reaction rate.
If two enzymes, in different pathways, compete for the same substrate, then knowing the values of Km and Vmax for both enzymes permits prediction of the metabolic fate of the substrate and the relative amount that will flow through each pathway under various conditions.
Examples of enzymes regulated by covalent modification include many enzymes and non-protein helpers such as Iron (Fe 2 +), Magnesium (Mg 2 +), Coenzymes, and Cofactors.
Allosteric Regulation of Threonine Deaminase in bacteria involves binding of small molecules to the allosteric site, leading to a change in the enzyme conformation (active site).
Many enzymes are also regulated by covalent modification, which involves the addition or removal of specific chemical groups to activate or inactivate the enzyme.
Mode of regulation of metabolic pathways such as glycolysis (glucose to pyruvate) involves P sending back a signal to slow the line to inhibit enzyme 1.
Process of negative feedback control involves an increase in P leading to a decrease in its rate of production by inhibiting Enzyme 1 at the site topographically distinct from the site of active site (allosteric site).
Defect in Allosteric Regulation can lead to conditions such as Gout, where Phosphoribosylpyrophosphate (PRPP) is high in Red Blood Cells (RBC) of patients with gout.